Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant …
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant …
Filed under: Seattle Drug Treatment
SEATTLE, Oct. 2, 2012 — /PRNewswire/ — Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced that OPAXIO (paclitaxel poliglumex) has been granted orphan-drug designation by the U.S Food and Drug Administration ("FDA") for the treatment of …
Read more on The Herald | HeraldOnline.com
Op-ed: Don't legalize marijuana. It's addictive
Filed under: Seattle Drug Treatment
As doctors who have practiced addiction medicine for decades, we're seeing unprecedented levels of marijuana addiction today. Treatment admissions for marijuana-use disorders have dramatically increased, accounting for 18 percent of admissions in 2010 …
Read more on The Seattle Times
Prostate cancer drug prolongs life
Filed under: Seattle Drug Treatment
Dr. Montgomery is affiliated with the University of Washington Medical Center and Seattle Cancer Care Alliance. The current prognosis for men diagnosed with castration-resistant prostate cancer is very poor. “Not many years ago, the only option we had …
Read more on CBS42
Seattle conference to focus on trauma and addiction treatment
Filed under: Seattle Drug Treatment
That's why Hazelden, the nation's leading provider of addiction recovery services and information, will host a daylong conference on "Treating Trauma and Addiction," October 5 in Seattle at the Marriott Waterfront. The conference will bring together …
Read more on News-Medical.net
More Seattle Drug Treatment Resources
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation For Malignant Brain Cancer From FDASEATTLE, Oct. 2, 2012 /PRNewswire/ — Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced that OPAXIO (paclitaxel poliglumex) has been granted orphan-drug designation by the U.S … Read News
Cell Therapeutics OPAXIO Gets Orphan Drug Designation For Malignant Brain CancerCell Therapeutics OPAXIO Gets Orphan Drug Designation For Malignant Brain Cancer … Read News